Roche reports strong sales growth in the first nine months ...

Roche reports strong sales growth in the first nine months of 2017 ... For forms of blood cancer, rheumatoid arthritis and certain types of vasculitis. Sales continued to rise, supported by growth in the oncology as well as in the immunology segments. The largest sales increases were recorded in the US, driven by immunology, and the ... ................
................